COMMENT

Mapping biologically active chemical space to accelerate drug discovery

A specialized platform for innovative research exploration — ASPIRE — in preclinical drug discovery could help study unexplored biologically active chemical space through integrating automated synthetic chemistry, high-throughput biology and artificial intelligence technologies.
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Contact

Search for this author in:

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Search for this author in:

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Search for this author in:

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Search for this author in:

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Reviews Drug Discovery 18, 83-84 (2018)

doi: 10.1038/d41573-018-00007-2

References

  1. 1.

    Oprea, T. I. et al. Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov. 17, 317–332 (2018).

  2. 2.

    Mullard, A. The drugmaker’s guide to the galaxy. Nature 549, 445–447 (2017).

  3. 3.

    Schneider, G. Automating drug discovery. Nat. Rev. Drug Discov. 17, 97–113 (2018).

  4. 4.

    Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536–541 (2015).

  5. 5.

    Lowe, D. AI designs organic syntheses. Nature 555, 592–593 (2018).

Download references

Supplementary Information

  1. 41573_2019_CM16292814_MOESM1_ESM

Competing Financial Interests

The authors declare no competing interests.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.